These 4 Companies Are Creating the Next Generation of Cancer Treatments

Filed under: Drug Treatment Seattle

September 24, 2013 | Comments (0). Many biotech investors are interested in antibody-drug conjugates, or ADCs, these days, and for good reason — if they catch on as a mainstream cancer treatment, they could render traditional chemotherapy obsolete …
Read more on Motley Fool

AZ buys into ADC sector with 0m Spirogen deal

Filed under: Drug Treatment Seattle

ADCs combine the targeting power of antibodies with another active agent – typically a cytotoxic drug – that is designed to boost their activity but minimise side effects on other cells and tissues in the body. The field is still in its infancy but is …
Read more on PMLiVE

Seattle Genetics (SGEN) Updates on Several ADCETRIS Presentations Made at …

Filed under: Drug Treatment Seattle

ADCETRIS was granted accelerated approval by the U.S. Food and Drug Administration (FDA) in August 2011 for relapsed HL and sALCL and conditional marketing authorization by the European Commission in October 2012 for relapsed or refractory HL and …
Read more on StreetInsider.com (subscription)

One and done in Game 1

Filed under: Drug Treatment Seattle

It has been 20 years since the Red Sox were no-hit, Seattle's Chris Bosio doing the deed on April 22, 1993, and three years since the Philadelphia Phillies' Roy Halladay tossed the last postseason no-hitter. Tigers starter Anibal Sanchez and four …
Read more on Boston Herald